{
    "title": "Intercept to go back to FDA with its NASH treatment application",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10991359/Intercept-resubmit-NASH-treatment-application-FDA-review.html",
    "date": "2022-07-07",
    "keywords": [
        "liver",
        "disease",
        "company",
        "treatment",
        "fda",
        "approval",
        "therapy",
        "fibrosis",
        "data",
        "analyst",
        "opportunity",
        "benefit",
        "application",
        "food",
        "drug",
        "administration",
        "regulator",
        "light",
        "acid",
        "steatohepatitis",
        "accumulation",
        "intercept",
        "reduction",
        "placebo",
        "analysis",
        "michael",
        "anything",
        "httpsreutrs3uy0ysl",
        "time",
        "submit",
        "latestage",
        "study",
        "foundation",
        "nordisk",
        "pfizer",
        "cholangitis",
        "pbc",
        "safety",
        "framework",
        "mayank",
        "mamtani",
        "capital",
        "allocation",
        "commercialization",
        "reporting",
        "roy",
        "leroy",
        "leo",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}